AIM ImmunoTech, Inc. (AIM)
0.562
+0.02
(+2.99%)
USD |
NYAM |
Apr 16, 16:00
0.5586
0.00 (0.00%)
Pre-Market: 09:07
AIM ImmunoTech Research and Development Expense (Quarterly) : 0.622M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agenus, Inc. | 7.511M |
| Curis, Inc. | 5.825M |
| Plus Therapeutics, Inc. | 2.941M |
| Windtree Therapeutics, Inc. | 1.537M |
| Halozyme Therapeutics, Inc. | 31.90M |